I remember a few years ago when Joe said based on Excellagan, there was expected I believe around 280 million dollars in future sales alone I think for the VA hospitals. That was pre covid and of course Covid ruined that expectation, so that is not Joe's fault by any means.
But, what that does show is the huge potential of the product in the VA hospitals and with the sales that will be conducted overseas and in hospitals outside of the VA, Excellagon should be a mainstay for Generex for years to come.
I say this because while we do talk about the IND and the IPO alot, we do need to hear about Excellagon. We need to hear if anything is going on with the VA hospitals, the hospital in New York, if it's getting sold overseas, everything. Do they have the sales force in place? How are the batch making processes going? Are they getting orders?
We are in Covid and we will be in Covid. It isn't going away. That's an accepted fact. So, is the product being worked back into the channels again and how is it doing in those channels?
But, what that does show is the huge potential of the product in the VA hospitals and with the sales that will be conducted overseas and in hospitals outside of the VA, Excellagon should be a mainstay for Generex for years to come.
I say this because while we do talk about the IND and the IPO alot, we do need to hear about Excellagon. We need to hear if anything is going on with the VA hospitals, the hospital in New York, if it's getting sold overseas, everything. Do they have the sales force in place? How are the batch making processes going? Are they getting orders?
We are in Covid and we will be in Covid. It isn't going away. That's an accepted fact. So, is the product being worked back into the channels again and how is it doing in those channels?
1
